• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    N

    Norwegian Cancer Society

    EST. 1938
    341论文总数
    3.2万引用总数

    The Norwegian Cancer Society (Norwegian: Kreftforeningen) is a non-profitmaking organisation in Norway.

    论文量&引用量时间轴

    机构学者

    排序
    Jahn Marthin Nesland
    Jahn Marthin Nesland
    Department of Pathology, Oslo University Hospital
    论文:23引用:0H-index:0
    Sophie D. Fosså
    Sophie D. Fosså
    Department of Oncology, Division of Cancer Medicine, Oslo University Hospital;National Resource Center for Late Effects after Cancer Treatment, Division of Cancer Medicine, Oslo University Hospital
    论文:14引用:0H-index:0
    Albrecht Reith
    Albrecht Reith
    Laboratory for Electron Microscopy and Morphometry, The Norwegian Radium Hospital
    论文:9引用:0H-index:0
    Manuel Sobrinho-Simões
    Manuel Sobrinho-Simões
    Cancer Signalling & Metabolism Group, Ipatimup Institute of Molecular Pathology and Immunology, University of Porto
    论文:7引用:0H-index:0
    Steinar Funderud
    Steinar Funderud
    DEPT IMMUNOL, NORWEGIAN RADIUM HOSP
    论文:7引用:0H-index:0
    Kjell Nustad
    Kjell Nustad
    Department of Medical Biochemistry, Oslo University Hospital
    论文:6引用:0H-index:0
    Heidi Kiil Blomhoff
    Heidi Kiil Blomhoff
    Institute Group of Basic Medical Sciences, University of Oslo
    论文:6引用:0H-index:0
    Ruth Holm
    Ruth Holm
    University of Oslo
    论文:6引用:0H-index:0
    Per Kolstad
    Per Kolstad
    Department of Environmental Technology, Norwegian Geotechnical Institute
    论文:5引用:0H-index:0

    论文(341)

    年份
    起
    –
    止
    排序
    1Effectiveness of an Artificial Intelligence-Based Self-Management Intervention to Support Sick-Listed Individuals with Musculoskeletal Disorders in Norway: Rationale and Protocol for the SmaRTWork Randomised Controlled Trial
    Lene Aasdahl,Kerstin Bach,Tom Ivar Lund Nilsen, Stuart Gallina Ottersen, Nina E Klevanger, Christoph Eder, Cecilie Krage Øverås,Fredrik Granviken, Julia Debik, Lars Christian Naterstad Lervik, Heidi Fossen, Anita Formo Bones,

    Introduction Long-term sickness absence represents a major public health challenge with far-reaching consequences for both individuals and society. Musculoskeletal disorders (MSDs) are among the leading causes of sickness absence. Although mobile apps show promise for supporting self-management of MSDs, high-quality evidence remains limited, and outcomes related to work participation are rarely examined. This trial aims to evaluate whether an individually tailored, app-based self-management intervention (SmaRTWork), provided in addition to usual care, improves return-to-work compared with usual care alone among individuals on sick leave due to MSDs. Methods and analysis We will conduct a randomised controlled trial with two parallel arms: 1) SmaRTWork in addition to usual care and 2) usual care alone. Individuals 20–59 years old who have been sick-listed for <12 weeks due to back, neck or widespread pain will be recruited through clinicians in primary health care. Eligible participants are randomised 1:1 to one of the two arms. We aim to include 298 participants, 149 in each arm. The primary outcome is time to sustainable return-to-work, defined as one consecutive month without receiving medical benefits, assessed over a 12-month period using registry data. Secondary outcomes include health-related measures assessed at baseline, 3, 6 and 12 months. The trial will also incorporate qualitative studies, a process evaluation and a health economic evaluation. Ethics and dissemination The trial is approved by the Committees for Clinical Trials of Pharmaceuticals and Medical Devices (Ref. 563919). Results will be published in peer-reviewed journals and presented at national and international conferences. Trial registration NCT07034040 .

    2026BMJ open(2026)
    引用
    AI阅读
    加入学术空间
    2Digital Home-Based Multimodal Prehabilitation of Colorectal Cancer Patients Prior to Surgery (the Dhope Study): a Non-Inferiority Clinical Trial Protocol
    Guro Kleve, Chiara Dalla Santa, Felicia Kristiansen, Marita Tegnander, Victoria Buch, Cecilie Steen Hagemann, Marianne Helgheim, Parasto Engene, Henri Pesonen, Maiken Kojen Kleveland, Greta Lyster Hverven, Tormod Skogstad Nilsen,

    BackgroundCancer surgery is associated with risk of complications and loss of function. Vulnerability factors, such as advanced age, malnutrition, smoking, comorbidity, frailty, and low socioeconomic status increase the risk. Lifestyle intervention prior to surgery, known as prehabilitation, often include physical activity, nutritional support, psychological coaching, and smoking cessation, increase functional reserves and reduce postoperative complications. Most importantly, it prevents loss of functional capacity and dependence.MethodsThe dHOPE study is a three-armed, open-labelled, parallel-group randomized controlled trial (RCT) with non-inferiority design to compare a digital home-based prehabilitation program with a hospital-based program or no organized prehabilitation. In addition, the dHOPE study aims to identify measurable parameters reflecting the effect of prehabilitation, thus preparing for future personalization of the prehabilitation programs.DiscussionThe feasibility of multimodal prehabilitation is threatened by low compliance to hospital-based programs due to burdensome commuting, even in central and metropolitan areas. In sparsely populated countries, this challenge is even more pronounced. To ensure equal healthcare to all citizens regardless of address or economic situation, there is a need to transfer the prehabilitation program to the patients’ homes. Thus, the primary hypothesis of dHOPE is that a digital home-based program is not inferior to a hospital-based program. Moreover, given the patient diversity, prehabilitation must be personalized to meet individual profiles or needs. An exploratory subtask of dHOPE is to confirm the utility of clinical, genetic, and molecular factors in evaluating prehabilitation response ultimately to identify new biomarkers and develop medical software for individual risk stratification and development of personalized prehabilitation programs. Clinical Trial registrationhttps://clinicaltrials.gov/, identifier (NCT06231576).

    2025Frontiers in digital health(2025)引用:1
    引用
    AI阅读
    加入学术空间
    3Exploring Men’s Cancer Journeys in Norway: a Comprehensive Survey on Diet, Supplements, and Use of Complementary and Alternative Therapies
    Agnete E. Kristoffersen,Kiwumulo Nakandi,Arne Johan Norheim,Mona Bjelland,Jorunn V. Nilsen,Eran Ben-Arye

    BackgroundEach year, over 20,000 men are diagnosed with cancer in Norway, and approximately 150,000 men who have previously been diagnosed with cancer are currently alive. Many of these cancer survivors encounter a range of challenges, including fatigue, sexual dysfunction, urinary issues, and pain, all of which can significantly impact their quality of life. Consequently, a substantial number of men seek support beyond conventional healthcare. This study aims to investigate the motivations behind the use of Complementary and Alternative Medicine (CAM) and dietary changes/supplements in men with cancer in Norway, and further explore their communication with healthcare providers, self-reported effects and adverse effects, and the sources of information they rely on regarding these practices.MethodIn collaboration with the Norwegian Cancer Society (NCS), we conducted an online cross-sectional study involving participants of their user panel who have current or past experiences with cancer (n = 706), of whom 218 identified as men. The study was conducted during the autumn of 2021, employing a modified cancer-specific version of the International Questionnaire to Measure Use of Complementary and Alternative Medicine (I-CAM-Q). A total of 153 men agreed to participate, yielding a response rate of 70%.ResultsA large proportion of the respondents used CAM (62%), dietary supplements (65%), and/or adjusted their diet (81%) to boost their immune systems and increase their quality of life. The dietary adjustments involved eating more fruits, vegetables, fish, and whole grains. Many participants also used relaxation techniques and visited CAM providers to enhance quality of life. Most participants reported better health outcomes as a result of these interventions. The Internet and healthcare professionals were the main source of information, although many did not disclose their dietary changes and CAM therapy use with healthcare professionals.ConclusionBy leveraging these insights, healthcare providers, policymakers, and researchers can collectively work towards a more holistic and patient-centred approach to cancer care, ultimately improving the overall well-being and quality of life for male cancer survivors.

    2025BMC Complementary Medicine and Therapies(2025)引用:1
    引用
    AI阅读
    加入学术空间
    4Exploring Dietary Changes and Supplement Use among Cancer Patients in Norway: Prevalence, Motivations, Disclosure, Information, and Perceived Risks and Benefits: a Cross Sectional Study
    Agnete E. Kristoffersen,Trine Stub,Jorunn V. Nilsen,Johanna Hök Nordberg,Ann Ragnhild Broderstad,Barbara Wider,Mona Bjelland

    Abstract Background Cancer is the leading cause of death in Norway, with prostate, breast, lung, and colon cancers being the most prevalent types. Adopting a healthy and varied diet can help reduce cancer risk and recurrence. However, access to dietary counselling remains limited for cancer patients in Norway. This study aimed to investigate the prevalence of dietary supplement use and dietary changes made by cancer patients and survivors. Additionally, it sought to explore the reason(s) for such practices, communication with healthcare providers, sources of information, and reported benefits and potential harms resulting from these changes and supplement use. Methods Conducted in collaboration with the Norwegian Cancer Society (NCS), this online cross-sectional study targeted members of their user panel who had either current or previous cancer (n = 706). The study took place in September/October 2021, utilizing a modified cancer-specific version of the International Questionnaire to Measure Use of Complementary and Alternative Medicine (I-CAM-Q). Out of 468 participants (315 women and 153 men), 67.2% consented to participate. Between-group analyses were conducted using Pearson chi-square tests and Fisher exact tests for categorical variables, while independent sample t-tests were applied for continuous variables. Results The majority of the participants (97%) reported making changes to their diet (78%) and/or incorporating dietary supplements (73%) in response to their cancer diagnosis. The primary goal of these changes was to strengthen their body and immune system. Almost half of the participants (49%) reported that they found these changes beneficial and discussed them openly with their healthcare providers, with family physicians being the most common point of discussion (25%). Adverse effects were reported by only a few participants, mostly mild. Information about dietary changes and supplements was primarily sourced from the internet or healthcare providers. Conclusions This study highlights that most individuals affected by cancer attribute to dietary adjustment. It also emphasizes the importance of addressing adherence to dietary recommendations and using reliable sources of information. Additionally, the study highlights the potential, yet currently underutilized, role of healthcare professionals in initiating dialogues about dietary interventions to address any unmet needs of patients. Such proactive engagement may contribute to the promotion of reliable sources of information and the prevention of non-evidence-based and potentially harmful diets or supplement adoption.

    2024BMC Nutrition(2024)引用:4
    引用
    AI阅读
    加入学术空间
    5Hvordan Kan Vi Bli Enda Bedre Rådgivere?
    Mona Bjelland, Kjersti Birketvedt, Mina Susanne Weedon-Fekjær
    2024Norsk tidsskrift for ernæring(2024)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 341 篇论文

    合作机构(100)

    Oslo University Hospital, Radiumhospitalet合作论文 61
    奥斯陆大学合作论文 31
    挪威奥斯陆大学医院合作论文 12
    赫尔辛基大学合作论文 10
    隆德大学合作论文 10
    Cancer Registry of Norway合作论文 10
    挪威科技大学合作论文 9
    乌梅奥大学合作论文 7
    科赫综合癌症研究中心合作论文 6
    卑尔根大学合作论文 6

    机构统计